# Major Recall Alert: Proguanil Tablet B.P 100mg Recalled Due to Circulation of Counterfeit Proguanil Tablets (Projeanil and Re-Granil) with Fake NAFDAC Registration Number
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued an urgent warning following the discovery of counterfeit Proguanil Tablet B.P 100mg (marketed as Projeanil and Re-Granil) in Nigeria. The fake products have been found to carry a fraudulent NAFDAC registration number. This poses a serious health risk to users, particularly those relying on the medication for its anti-malaria properties.
If you’ve purchased or been prescribed these products, it is crucial to verify their authenticity immediately and heed NAFDAC’s recommendations to avoid potentially harmful consequences.
---
## Why This Recall Is Important
Counterfeit medications are a growing global problem, and their circulation causes grave risks to public health. In this case, the counterfeit Proguanil tablets jeopardize the treatment of malaria, a life-threatening disease prevalent in Nigeria. These falsified versions of Projeanil and Re-Granil not only fail to provide effective protection but may also contain harmful substances, further endangering lives.
Key concerns include:
- The use of a **fake NAFDAC registration number (04-6433)** to create a false sense of legitimacy.
- Possible inclusion of ineffective or harmful ingredients in the counterfeit tablets.
- Lack of quality control in production, increasing health risks when consumed.
Health authorities, caregivers, and consumers must act promptly to prevent the continued circulation and use of these dangerous counterfeit drugs.
---
## Details of the Recall
If you’re using or distributing Proguanil Tablet B.P 100mg, here are the critical details of the recall:
- **Product Name**: Proguanil Tablet B.P 100mg
- **Brands Affected**: Projeanil and Re-Granil
- **Reason for Recall**: Circulation of counterfeit drugs with fake NAFDAC registration numbers.
- **NAFDAC's Alert Number**: Public Alert No. 023/2026
- **Images of Counterfeit Products**:
- 
- 
- 
- 
NAFDAC urges healthcare professionals, pharmacies, distributors, and consumers to **immediately discontinue the distribution, sale, or use of these counterfeit products.** Any suspected falsified medicines should be reported via the nearest NAFDAC office or official contact channels.
For full details, refer to the official NAFDAC notice [here](https://nafdac.gov.ng/public-alert-no-023-2026-alert-on-counterfeit-brands-of-proguanil-projeanil-and-re-granil-tablet-b-p-100mg-with-fake-nafdac-registration-number-04-6433-found-in-nigeria/).
---
## What You Should Do
To protect yourself and your loved ones, follow these measures:
- **Check all Proguanil tablets in your possession** for their authenticity. Avoid using Projeanil or Re-Granil labeled with the fake NAFDAC registration number.
- **Discontinue all sales and distribution**, even if you suspect the product might be falsely labeled as authentic.
- **Contact NAFDAC** to report any counterfeit medicines or suspicious incidents.
- **Seek medical advice immediately** if you’ve consumed the counterfeit Proguanil tablets and experience any adverse symptoms.
Remember, staying vigilant can save lives. Spread the word to prevent others from unknowingly using counterfeit medications.
---
## Stay Safe – Get Instant Recall Alerts
Counterfeit medications are a serious threat to public health, but you can stay informed and protected. Stay on top of all product recalls by downloading the NAFDAC mobile app. Through the app, you’ll receive real-time updates on counterfeit products, report fake drugs, and verify product authenticity instantly.
👉 **Download the NAFDAC mobile app now and empower yourself with reliable information to safeguard your health.**
For additional information, visit [NAFDAC’s official website](https://nafdac.gov.ng/). Stay informed, save lives, and keep your community safe.
---
By taking immediate action and spreading awareness about this recall, you can play a crucial role in helping to eradicate counterfeit medicines from circulation and safeguard public health.